Phyllis Gotlib Sells 3,574 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWLGet Free Report) insider Phyllis Gotlib sold 3,574 shares of the company’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $4.06, for a total value of $14,510.44. Following the sale, the insider owned 123,577 shares of the company’s stock, valued at $501,722.62. The trade was a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Phyllis Gotlib also recently made the following trade(s):

  • On Wednesday, October 1st, Phyllis Gotlib sold 4,959 shares of American Well stock. The stock was sold at an average price of $6.11, for a total transaction of $30,299.49.

American Well Stock Up 1.2%

AMWL opened at $4.13 on Friday. The stock has a market cap of $67.61 million, a PE ratio of -0.57 and a beta of 1.28. The company has a fifty day moving average of $5.00 and a 200-day moving average of $6.53. American Well Corporation has a twelve month low of $3.71 and a twelve month high of $12.95.

American Well (NYSE:AMWLGet Free Report) last issued its earnings results on Tuesday, November 4th. The company reported ($1.74) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.83) by $0.09. American Well had a negative return on equity of 39.80% and a negative net margin of 42.80%.The company had revenue of $56.29 million for the quarter, compared to analyst estimates of $54.56 million. Sell-side analysts anticipate that American Well Corporation will post -9.34 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. OMERS ADMINISTRATION Corp boosted its stake in American Well by 207.9% during the first quarter. OMERS ADMINISTRATION Corp now owns 32,331 shares of the company’s stock worth $255,000 after acquiring an additional 21,831 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of American Well by 280.6% during the first quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock valued at $510,000 after purchasing an additional 47,745 shares in the last quarter. Jane Street Group LLC boosted its position in shares of American Well by 232.9% in the 1st quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock worth $505,000 after purchasing an additional 44,852 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of American Well by 19.5% in the 1st quarter. Acadian Asset Management LLC now owns 188,217 shares of the company’s stock worth $1,481,000 after buying an additional 30,669 shares during the last quarter. Finally, Corton Capital Inc. increased its position in American Well by 71.7% during the 2nd quarter. Corton Capital Inc. now owns 27,402 shares of the company’s stock valued at $244,000 after buying an additional 11,445 shares in the last quarter. 56.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on AMWL shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Well in a research note on Wednesday, October 8th. Wall Street Zen cut shares of American Well from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Wells Fargo & Company dropped their price target on American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Finally, Stifel Nicolaus lowered their price objective on shares of American Well from $8.00 to $6.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $8.33.

Get Our Latest Stock Report on AMWL

American Well Company Profile

(Get Free Report)

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

Featured Stories

Insider Buying and Selling by Quarter for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.